Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis

被引:65
作者
Cavazzini, Francesco [1 ]
Hernandez, Jose Angel [2 ]
Gozzetti, Alessandro [3 ]
Rossi, Antonella Russo [1 ]
De Angeli, Cristiano [1 ]
Tiseo, Ruana [1 ]
Bardi, Antonella [1 ]
Tammiso, Elisa [1 ]
Crupi, Rosaria [3 ]
Lenoci, Maria Pia [3 ]
Forconi, Francesco
Lauria, Francesco
Marasca, Roberto [4 ]
Maffei, Rossana [4 ]
Torelli, Giuseppe [4 ]
Gonzalez, Marcos [5 ,6 ]
Martin-Jimenez, Patricia [5 ,6 ]
Hernandez, Jesus Maria [5 ,6 ]
Rigolin, Gian Matteo [1 ]
Cuneo, Antonio [1 ]
机构
[1] Univ Ferrara, Sect Haematol, Dept Biomed Sci & Adv Therapies, I-44100 Ferrara, Italy
[2] Hosp Fuenlabrada, Madrid, Spain
[3] Univ Siena, Dept Med & Immunol Sci, Div Haematol & Transplants, I-53100 Siena, Italy
[4] Univ Modena, Dept Haematol & Oncol, I-41100 Modena, Italy
[5] Univ Salamanca, CSIC, Hosp Univ Salamanca, Hematol Serv, E-37008 Salamanca, Spain
[6] Univ Salamanca, CSIC, Ctr Invest Canc, E-37008 Salamanca, Spain
关键词
chronic lymphocytic leukaemia; cytogenetics; prognostic factors; IgH; FISH;
D O I
10.1111/j.1365-2141.2008.07227.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immunophenotypic studies, fluorescence in situ hybridization (FISH) and conventional karyotyping were used to define the clinicobiological significance of 14q32 translocations involving the immunoglobulin gene locus (14q32/IGH) in 252 chronic lymphocytic leukaemia (CLL) patients. The following regions were studied: 13q14, centromere 12, 6q21; 11q22/ATM; 17p13/TP53, 14q32/IGH. Patients were classified as group 1 (favourable, i.e. 13q-single or normal), group 2 (intermediate risk, i.e. +12, 6q-, 1-2 anomalies), group 3 (unfavourable, i.e. 17p-, 11q-, complex karyotype), or group 4 (14q32/IGH translocation). Endpoints were treatment-free survival (TFS) and overall survival (OS). One hundred and ten patients were included in group 1, 99 in group 2, 25 in group 3 and 18 in group 4. 14q32/IGH translocation partners were identified in eight cases (BCL2 in five cases, BCL11A, CCND3 and CDK6 in one case each). group 4 showed shorter TFS versus groups 2 and 1 (25% patients treated at 2 months vs. 12 (P = 0.02) and 20 months (P = 0.002), respectively) and shorter OS (25% patients dead at 18 months versus 50 (P = 0.0003) and > 60 months (P < 0.0001) respectively. The 14q32/IGH translocation maintained prognostic significance at multivariate analysis on TFS (P = 0.025) and OS (P < 0.001), along with advanced stage and CD38(+). These findings show that the 14q32/IGH translocation predicts for an unfavourable outcome in CLL and that this cytogenetic subset might be included as a separate entity in a hierarchical cytogenetic classification of CLL.
引用
收藏
页码:529 / 537
页数:9
相关论文
共 43 条
[41]   Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies [J].
Sonoki, T ;
Harder, L ;
Horsman, DE ;
Karran, L ;
Taniguchi, I ;
Willis, TG ;
Gesk, S ;
Steinemann, D ;
Zucca, E ;
Schlegelberger, B ;
Solé, F ;
Mungall, AJ ;
Gascoyne, RD ;
Siebert, R ;
Dyer, MJS .
BLOOD, 2001, 98 (09) :2837-2844
[42]   Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine [J].
Van Den Neste, E. ;
Robin, V. ;
Francart, J. ;
Hagemeijer, A. ;
Stul, M. ;
Vandenberghe, P. ;
Delannoy, A. ;
Sonet, A. ;
Deneys, V. ;
Costantini, S. ;
Ferrant, A. ;
Robert, A. ;
Michaux, L. .
LEUKEMIA, 2007, 21 (08) :1715-1722
[43]   Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia [J].
Zenz, Thorsten ;
Doehner, Hartmut ;
Stilgenbauer, Stephan .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (03) :439-453